Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.11 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.428NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.428NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.355NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.355NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.355NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.34.1.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.34.1.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.34.1.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.71 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.71 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.71 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.33.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.33.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.33.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.52NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.52NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.52NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.465NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.465NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.465NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21947US
B.1.160.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18194.4China
AY.4.2.5 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.4.2.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.2.5 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XFNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XFNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
S.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
S.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
S.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.221.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.221.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.215NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.215NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.215NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.82NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.82NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.82NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.462NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used